Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DMPK 3' untranslated repeat expansions in unexplained sudden cardiac death in the young.

European heart journal·2026
Same author

Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

European heart journal·2025
Same author

Clinical Validity of Autosomal Dominant <i>ALPK3</i> Loss-of-Function Variants as a Cause of Hypertrophic Cardiomyopathy.

Circulation. Genomic and precision medicine·2025
Same author

A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets.

European heart journal·2025
Same author

ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel: Reappraisal of Genes associated with Hypertrophic Cardiomyopathy.

medRxiv : the preprint server for health sciences·2024
Same author

A case series of patients with filamin-C truncating variants attending a specialized cardiac genetic clinic.

European heart journal. Case reports·2023

Related Experiment Video

Updated: Jun 22, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.8K

Splicing Functional Assays Into the Genetic Testing Pipeline

Emma S Singer1,2, Richard D Bagnall1,2

  • 1Agnes Ginges Centre for Molecular Cardiology at Centenary Institute (E.S.S., R.D.B.), The University of Sydney, NSW, Australia.

Circulation. Genomic and Precision Medicine
|November 9, 2022
PubMed
Summary

No abstract available in PubMed .

Keywords:
arrhythmiaclinicalfunctional assaygenetic testheart disease

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.0K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

2.8K

Related Experiment Videos

Last Updated: Jun 22, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.8K
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.0K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

2.8K